| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DEXCOM INC | 100,000 | 8,766,000 | 0.97% | ||
| 52 | COLLEGIUM PHARMACEUTICAL INC COM | 455,515 | 8,773,000 | 0.97% | ||
| 53 | BLUEPRINT MEDICINES CORP COM | 298,870 | 8,876,000 | 0.98% | ||
| 54 | INC RESH HLDGS INC | 200,000 | 8,916,000 | 0.98% | ||
| 55 | CONTRAFECT CORP COM | 3,840,966 | 9,526,000 | 1.05% | ||
| 56 | GEMPHIRE THERAPEUTICS INC | 900,000 | 9,828,000 | 1.08% | ||
| 57 | ADVAXIS INC COM NEW | 920,915 | 9,845,000 | 1.09% | ||
| 58 | INVUITY INC | 767,466 | 10,530,000 | 1.16% | ||
| 59 | AGENUS INC | 1,578,106 | 11,331,000 | 1.25% | ||
| 60 | CELLECTIS S A | 498,117 | 11,995,000 | 1.32% | ||
| 61 | PORTOLA PHARMACEUTICALS INC | 596,000 | 13,535,000 | 1.49% | ||
| 62 | CORBUS PHARMACEUTICALS HLDGS | 2,000,000 | 13,580,000 | 1.50% | ||
| 63 | CHINA BIOLOGIC PRODS INC | 112,867 | 14,050,000 | 1.55% | ||
| 64 | COHERUS BIOSCIENCES INC COM | 576,106 | 15,428,000 | 1.70% | ||
| 65 | SORRENTO THERAPEUTICS INC COM NEW | 2,121,013 | 16,417,000 | 1.81% | ||
| 66 | WAVE LIFE SCIENCES LTD | 507,907 | 16,492,000 | 1.82% | ||
| 67 | Protagonist Therapeutics, Inc. | 800,000 | 16,904,000 | 1.86% | ||
| 68 | OMEROS CORP | 1,695,000 | 18,916,000 | 2.09% | ||
| 69 | NEUROCRINE BIOSCIE COM USD0.001 | 398,301 | 20,170,000 | 2.22% | ||
| 70 | MACROGENICS INC | 707,978 | 21,176,000 | 2.34% | ||
| 71 | GALAPAGOS NV | 334,044 | 21,441,000 | 2.36% | ||
| 72 | QUOTIENT LTD | 2,787,717 | 21,800,000 | 2.40% | ||
| 73 | ACLARIS THERAPEUTICS INC COM | 901,286 | 23,082,000 | 2.55% | ||
| 74 | CLOVIS ONCOLOGY INC | 650,000 | 23,433,000 | 2.58% | ||
| 75 | MYOKARDIA INC | 1,605,790 | 26,239,000 | 2.89% | ||
| 76 | ARDELYX INC COM | 2,071,964 | 26,811,000 | 2.96% | ||
| 77 | HERON THERAPEUTICS INC COM | 1,771,263 | 30,519,000 | 3.37% | ||
| 78 | EAGLE PHARMACEUTICALS INC COM | 455,995 | 31,920,000 | 3.52% | ||
| 79 | CLEARSIDE BIOMEDICAL INC | 1,988,208 | 34,496,000 | 3.80% | ||
| 80 | PROTEOSTASIS THERAPEUTICS IN COM | 2,350,000 | 36,636,000 | 4.04% | ||
| 81 | MINERVA NEUROSCIENCES INC COM | 2,800,000 | 39,522,000 | 4.36% | ||
| 82 | Theravance Biopharma Inc | 1,118,372 | 40,530,000 | 4.47% | ||
| 83 | NEVRO CORP COM | 491,044 | 51,260,000 | 5.65% | ||
| 84 | ALDER BIOPHARMACEUTICALS INC | 1,689,071 | 55,351,000 | 6.10% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001583977-16-000008, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
